SynthesisFrontiers in pharmacology2025

Comparative safety profile of tyrosine kinase inhibitors in NSCLC: a network meta-analysis of hypertension and thrombotic risks.

Mingming Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.